banner

MAKE PROTECTION YOUR SUPERPOWER

JARDIANCE^® PROTECTS BY reducing risk for adult patients with¹:

Thumbnail

CKD

reduced risk of CV death or Kidney disease progression^‡2

Thumbnail

HF

reduced risk of CV death or hospitalisation for HF^‡§3,4

Thumbnail

T2d and CVD

reduced risk of CV death^¶5

Jardiance reduce cardio-renal risk in T2D patients

20/12/2022 | Author: Boehringer Ingelheim

Jardiance Helped slow the decline in Kidney function for T2D patients

Document ID: PC-KW-100542